COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UC San Diego Hosts Kyoto Prize Laureate Honored cancer researcher to present free public lecture March 3

 

September 22, 2005  |  

Kyoto Prize Laureate Alfred G. Knudson Jr., MD, PhD, of the Fox Chase Cancer Center in Philadelphia, will discuss his groundbreaking work at a free lecture beginning at 4:30 p.m. March 3 in UC San Diego’s Price Center Theater.

A geneticist and physician, Knudson is internationally recognized for his "two-hit" theory of cancer causation, which explained the relationship between the hereditary and non-hereditary forms of a cancer and predicted the existence of tumor-suppressor genes that can suppress cancer cell growth. This now-confirmed theory has advanced understanding of errors in the genetic program that turn normal cells into cancer cells.

As one of three 2004 Kyoto Prize Laureates, Knudson’s appearance is sponsored by the Inamori Foundation of Japan, established in 1984 to honor and support individuals who have contributed greatly to scientific progress, cultural advance and human betterment.

He will be introduced by Ernest Beutler, MD, chairman of the Department of Molecular and Experimental Medicine at The Scripps Research Institute.

Other Kyoto Prize Laureates appearing in San Diego during the three-day Kyoto Laureate Symposium are computer scientist Alan Curtis Kay, PhD, who will speak at 9:30 a.m. March 3 at San Diego State University, and philosopher Jurgen Habermas, who will speak at 3 p.m. March 4 at the University of San Diego.

For further information contact Betsy Shed at 858-822-2611 or Kyoto@ucsd.edu.

#  #  #

News Media Contact: Nancy Stringer, 619-543-6163




Media Contact

Share This Article


Related News

3/3/2021
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical ...
3/2/2021
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.
3/2/2021
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
3/1/2021
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality ...



Follow Us